BCL9 and neoplasm: Alterations in the proportions of T-cell subpopulations, including decreased percentages of CD8+ T cells, tumor-associated macrophages, cancer-associated fibroblasts, tumor endothelial cells, tumor-associated neutrophils, and dendritic cells, indicate a complex TIME in tumors regulated by BCL9.